Brian Mueller - Jan 13, 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Laura Randall Woodhead, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Jan 13, 2023
Transactions value $
-$128,500
Form type
4
Date filed
1/17/2023, 08:57 PM
Previous filing
Dec 15, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $158K +2.5K +9.01% $63.10 30.2K Jan 13, 2023 Direct F1
transaction BMRN Common Stock Sale -$286K -2.5K -8.27% $114.50 27.7K Jan 13, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -2.5K -33.33% $0.00 5K Jan 13, 2023 Common Stock 2.5K $63.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.